Research ArticleResearchPatient Education

Two structured school programs produced similar adolescent anxiety and depression improvements

Psychological medicine (PubMed)Sep 4, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A multicenter trial found no significant anxiety or depression advantage for the Unified Protocol for Adolescents over structured progressive relaxation.

What NurseJet pulled from the source

The trial randomized 676 adolescents aged 12 to 18 with subthreshold emotional symptoms to UP-A or an active progressive-relaxation control. Both groups improved over time through 12 months.

Why this matters for nurses

Structured, accessible group support may help adolescents even when one specific protocol is not superior for the primary outcomes.

Bedside takeaway

Frame these programs as early support for subthreshold symptoms, not as a replacement for assessment or indicated mental-health treatment.

Key takeaways

Primary anxiety and depression outcomes did not differ significantly between groups.
At 12 months, UP-A showed marginally lower depressive symptoms and neuroticism.
UP-A favored several secondary outcomes, including hyperactivity, conduct problems, and total mental-health difficulties.

Practice implications

Frame these programs as early support for subthreshold symptoms, not as a replacement for assessment or indicated mental-health treatment.

Limitations & cautions

Abstract-only summary. The active control also received a structured intervention, and the primary between-group outcomes were not significant.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Psychological medicine (PubMed)

Psychological medicine (PubMed). A multicenter randomized controlled effectiveness trial of transdiagnostic treatment for adolescents with subthreshold anxiety and depressive symptoms.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42695201/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Trauma, violence & abuse (PubMed)Oct 17, 2026Systematic Review

A systematic review and meta-analysis of 20 emergency department studies encompassing 7,498 women found intimate partner violence was associated with a three-fold increased risk of suicide attempt, with psychological violence showing a stronger association than physical violence.

Emergency PsychAI summaryReview source

Systematic ReviewResearchWorkflowQuality ImprovementAI summary · original source linked below

Women experiencing intimate partner violence (IPV) and acute suicidality frequently seek medical evaluation in emergency departments (EDs), but the intersection between these two acute presentations is often overlooked during fast-paced triage. This systematic review, meta-analysis, and narrative synthesis synthesized 20 ED-based studies comprising 7,498 women across three global databases. Investigators used random-effects models and evaluated study quality with the Joanna Briggs Institute (JBI) checklist. Overall, 22% (95% CI: 11%–36%) of women presenting to the ED for suicide-related care had a history of physical IPV, while 13% (95% CI: 8%–18%) of women with known IPV histories reported active suicidality. A history of IPV was associated with a three-fold increase in the risk of suicide attempt (risk ratio [RR] 3.00; 95% CI: 1.39–6.47). Notably, psychological IPV demonstrated a stronger association with suicide risk (RR 3.23; 95% CI: 1.68–6.19) than physical IPV alone (RR 2.00; 95% CI: 1.26–3.17).

Key takeaways

Systematic review synthesized 20 emergency department studies encompassing 7,498 women.
Nearly 1 in 4 women (22%; 95% CI: 11%–36%) presenting to the ED with suicidality had experienced physical IPV.
IPV was associated with a three-fold higher risk of suicide attempt (RR 3.00; 95% CI: 1.39–6.47).
Psychological IPV showed a higher risk ratio for suicide attempts (RR 3.23; 95% CI: 1.68–6.19) than physical IPV (RR 2.00; 95% CI: 1.26–3.17).

Why this matters on shift

Emergency nurses are the primary healthcare professionals conducting universal triage, suicide risk screening (e.g., C-SSRS), and domestic violence assessments. Recognizing that nearly one-quarter of suicidal female presentations co-occur with IPV—and that non-physical, psychological abuse carries an even higher relative risk for suicide attempt—demands that ED nursing assessments integrate trauma-informed safety planning rather than treating suicidality and relationship violence in isolation.

Bedside takeaway

In an ED meta-analysis of 7,498 women, intimate partner violence tripled suicide attempt risk (RR 3.00), with psychological IPV (RR 3.23) linked more strongly than physical IPV (RR 2.00).

Nursing implications

Conduct routine IPV and suicide screenings privately away from companions or visitors, assess for emotional and psychological coercion even when physical injury is absent, and connect patients showing combined risk immediately to hospital social work, victim advocacy, and safe crisis intervention pathways.

Limitations & cautions

High between-study heterogeneity across meta-analytic models (I² > 75%); high risk of bias identified in half of the included primary studies; relied largely on cross-sectional self-reported survey measures.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Trauma, violence & abuse (PubMed). Intimate Partner Violence and Suicide Risk among Women Presenting to Emergency Departments: A Systematic Review, Meta-Analysis, and Narrative Synthesis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Pediatrics (PubMed)Oct 1, 2026Clinical Guideline

The American Academy of Pediatrics updated its clinical practice guideline for diagnosing and managing urinary tract infections in infants and children aged 8 days to 5 years with low medical complexity.

Peds EmergencyAI summaryReview source

Clinical GuidelineGuidelineQuality ImprovementPatient EducationAI summary · original source linked below

Urinary tract infections (UTIs) occur in approximately 7% of febrile infants and represent one of the most common bacterial infections in pediatric practice. Replacing the 2011 guidance, the American Academy of Pediatrics issued an updated clinical practice guideline with three companion technical reports for children 8 days to 5 years of age with low medical complexity. Developed using the GRADE framework with evidence-to-decision panels, the update provides eight Key Action Statements (two strong and six conditional recommendations ranging from low to very low certainty of evidence) and four Good Practice Statements. Core guidance spans the diagnostic evaluation of suspected UTI, targeted antimicrobial selection and treatment duration, indications for renal and bladder ultrasound and voiding cystourethrography, prevention of structural sequelae including vesicoureteral reflux, and structured screening and treatment for bowel and bladder dysfunction.

Key takeaways

AAP updated its pediatric UTI guideline for children aged 8 days to 5 years with low medical complexity.
Formulates 8 Key Action Statements (2 strong, 6 conditional) and 4 Good Practice Statements using GRADE methodology.
Refines diagnostic sampling criteria, acute antibiotic selection, and targeted duration to minimize antimicrobial resistance.
Updates indications for renal imaging, vesicoureteral reflux evaluation, and systematic management of bowel and bladder dysfunction.

Why this matters on shift

Pediatric and emergency nurses are central to identifying febrile infants at risk for UTI, executing proper catheterized or clean-catch urine specimen collection, and guiding families through antibiotic completion and scheduled follow-up imaging. Standardizing diagnostic thresholds prevents both delayed pyelonephritis treatment and unnecessary antibiotic exposure in young children.

Bedside takeaway

AAP updated its pediatric UTI guideline for children 8 days to 5 years, delivering 8 Key Action Statements on diagnostic sampling, targeted antibiotic therapy, imaging indications, and bowel-bladder dysfunction.

Nursing implications

Collect clean catheterized urine specimens rather than bag samples for culture in non-toilet-trained febrile infants, reinforce completing prescribed antibiotic courses with parents, and assess older toddlers for withholding and bowel/bladder dysfunction during discharge education.

Limitations & cautions

Guideline applies specifically to children with low medical complexity and excludes those with neurogenic bladder, known high-grade anatomical urological anomalies, or immunodeficiency; evidence certainty for several recommendations remains low to very low.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Pediatrics (PubMed). Clinical Practice Guideline for the Diagnosis and Treatment of Urinary Tract Infection in Children From 8 Days to 5 Years of Age.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

JAMA (PubMed)Oct 13, 2026Research Article

A phase 3 double-blind randomized clinical trial of 271 pediatric and young adult sickle cell patients halted early for futility found that intravenous arginine did not shorten time to pain crisis resolution or decrease total parenteral opioid requirements compared with placebo.

Emergency PedsAI summaryReview source

Research ArticleResearchMedication SafetyAI summary · original source linked below

Vaso-occlusive pain episodes represent the primary driver of emergency department visits and acute inpatient admissions in sickle cell disease (SCD). Patients frequently exhibit acute arginine deficiency during pain crises, and earlier phase 2 single-center trials suggested supplemental arginine might reduce hospital stay and opioid requirements. The multicenter phase 3 STArT trial, conducted across 10 US children's hospitals, evaluated whether intravenous arginine (200 mg/kg loading dose followed by 100 mg/kg every 8 hours) improved clinical outcomes compared to saline placebo in patients aged 3 to 21 years presenting to the ED with SCD pain requiring parenteral opioids. Among 274 randomized patients (271 received study drug; mean age 14.3 years; 51% male; 92% Black), the trial was halted early for futility. Time to crisis resolution—defined as time from initial infusion to final parenteral opioid dose—did not differ between arginine and placebo (median 60.8 hours [IQR 34.8–109.0] vs 65.8 hours [IQR 31.1–111.1]; absolute difference 7.2 hours; 95% CI -21.6 to 35.9). Secondary endpoints including cumulative parenteral opioid consumption, numeric pain scores, and safety profiles showed no significant differences.

Key takeaways

Multicenter double-blind phase 3 trial across 10 US children's hospitals enrolled 271 patients aged 3 to 21 years with severe sickle cell pain episodes.
Trial was terminated early by the data and safety monitoring board due to clinical futility.
Intravenous arginine did not shorten median time to pain crisis resolution compared with placebo (60.8 vs 65.8 hours; absolute difference 7.2 hours).
Arginine did not decrease cumulative parenteral opioid consumption or improve patient-reported pain intensity scores.

Why this matters on shift

Emergency and pediatric nurses are on the front lines of administering rapid parenteral analgesia and titrating scheduled opioids during severe sickle cell vaso-occlusive crises. Demonstrating that IV arginine confers no opioid-sparing or crisis-shortening benefit clarifies that nurses should continue prioritizing prompt evidence-based opioid titration, aggressive hydration, and individualized pain protocols.

Bedside takeaway

In a 271-patient multicenter pediatric trial halted early for futility, IV arginine did not shorten time to sickle cell pain crisis resolution (median 60.8 vs 65.8 hrs) or reduce total opioid requirements compared to placebo.

Nursing implications

Do not delay or alter standard guideline-directed parenteral opioid delivery for sickle cell pain crises in anticipation of arginine therapy, and maintain rigorous pain assessments and adverse-effect monitoring on shift.

Limitations & cautions

Trial halted prematurely for futility; enrolled cohort limited to pediatric and transitional young adult patients aged 3 to 21 years; findings may not generalize to older adult sickle cell populations.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

JAMA (PubMed). Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Meta-analysis of 20 emergency department studies links intimate partner violence to three-fold higher suicide attempt risk

AAP updates pediatric UTI clinical practice guideline with 8 key action statements for children 8 days to 5 years

Phase 3 STArT trial in 271 patients finds intravenous arginine does not shorten sickle cell acute pain crises or reduce opioid requirements